Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Mindset Pharma Inc
(CSE:
MSET
)
N/A
UNCHANGED
Last Price
Updated: 12:33 PM EDT, Oct 26, 2023
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
0
Open
-
Bid (Size)
0.5400 (7,000)
Ask (Size)
0.7500 (111,000)
Prev. Close
0.7400
Today's Range
N/A - N/A
52wk Range
0.5800 - 0.7500
Shares Outstanding
N/A
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Mindset Pharma and PharmAla Biotech Enter into Exclusive Sales Agreement
November 16, 2022
PharmAla will be the exclusive global reseller of Mindset’s cGMP psilocybin to appropriately licensed clinical researchers
From
PharmAla Biotech
Via
GlobeNewswire
PsychedelicNewsBreaks – Cybin Inc. (NEO: CYBN) (NYSE American: CYBN) Enters Agreement to Obtain Novel Catalog of Psychedelic-Based Compounds
September 27, 2022
Via
Investor Brand Network
Topics
Intellectual Property
Exposures
Intellectual Property
Performance
More News
Read More
The Power Play by The Market Herald Interviews James Lanthier of Mindset Pharma
January 05, 2022
From
The Market Herald
Via
AccessWire
Mindset Announces Participation at Upcoming Events in June 2021
June 01, 2021
Via
Newsfile
Topics
Cannabis
Exposures
Cannabis
Mindset Pharma Invited to Present at Canaccord Genuity 41st Annual Growth Conference
May 05, 2021
Via
Newsfile
Mindset Pharma Announces Positive Preclinical Results of Its Proprietary Next Generation DMT & 5-MeO-DMT Compounds
April 29, 2021
Via
Newsfile
Mindset Pharma Engages KCSA Strategic Communications to Provide Investor Relations Services
April 28, 2021
Via
Newsfile
Mindset Pharma Invited to Present at H.C. Wainwright "Psychedelics in Psychiatry and Beyond" Virtual Conference
April 26, 2021
Via
Newsfile
Mindset Pharma Announces Strong Confirmation of In Vivo Proof-of-Concept Across Its Entire New Drug Program Portfolio
April 20, 2021
Via
Newsfile
Topics
Intellectual Property
Exposures
Intellectual Property
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.